Browse by Poster Presenter

Type here to filter the list

F
Fürst, Jurij

Health Insurance Institute of Slovenia
(P-010) Slovenia versus the Netherlands: A Comparison of Opioid Prescription Strategies
Jurij Fürst
Favorite
Fadare, Joseph

Ekiti State University
(P-162) Key Opportunities and Future Direction for Drug Utilization Research in Africa
Joseph Fadare
Favorite
Faddoul, Najla

University of Florida,College of Pharmacy
(P-231) Association Between Non-adherence to Endocrine Therapy and the Risk of Recurrence Among Breast Cancer Survivors: A Systematic Literature Review
Najla Faddoul
Favorite
(P-232) Opioid Use Patterns Among Non-metastatic Cancer Survivors: A Systematic Literature Review
Najla Faddoul
Favorite
Faessen, Janine

VieCuri Medical Centre
(P-486) Diabetes Medication Use Is Associated with Higher Grade and Increased Probability of Muscle-invasive Tumour Disease in Patients with Urothelial Carcinoma
Janine Faessen
Favorite
Faillie, Jean-Luc

Department of Medical Pharmacology and Toxicology, CHU Montpellier University Hospital, Montpellier, France; Laboratory of Biostatistics, Epidemiology and Public Health (EA 2415), Faculty of Medicine, University of Montpellier, F-34295 Montpellier, France
(P-125) Risk of Thyroid Cancer with the Use of GLP-1 Receptor Agonists
Jean-Luc Faillie
Favorite
Falconer, Monique

FDA
(P-240) Analysis of COVID-19 Patient Experiences Reported Through Social Media
Monique Falconer
Favorite
Fan, Dongsheng

Department of Neurology, Peking University Third Hospital
(P-560) Urban Prevalence of Multiple Sclerosis in China: A Population-based Study in Six Provinces
Dongsheng Fan
Favorite
Fang, Gang

Division of Pharmaceutical Outcomes and Policy, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill
(P-400) Imbalanced Data Bias in Logistic Regression to Estimate Treatment Effects: Results from a Virtual Patient Cohort Simulation
Gang Fang
Favorite
FAN, Min

The University of Hong Kong
(P-077) Risk Factors for Carbapenemase-producing Enterobacteriaceae Colonization: A Population Based Nested Case-control Study
Min FAN
Favorite
Farel, Claire

University of North Carolina at Chapel Hill
(P-316) How COVID-19 Randomized Controlled Trials Reported on Demographic and Clinical Characteristics
Claire Farel
Favorite
Farley, Joel

University of Minnesota College of Pharmacy
(P-601) Patterns and Predictors of Stimulant Use During Pregnancy
Joel Farley
Favorite
Farnon, Eileen

Pfizer Inc.
(P-072) Deterministic Linkage of Pregnant Mothers and Their Newborns in Integrated US Insurance Claims and Electronic Health Record Data
Eileen Farnon
Favorite
Faruque, Junaid A. Y.

Leslie Dan Faculty of Pharmacy, University of Toronto
(P-381) Cardiovascular Safety Profile of Romosozumab: A Pharmacovigilance Analysis of the US Food and Drug Administration Adverse Event Reporting System (FAERS)
Junaid A. Y. Faruque
Favorite
Fauziyati, Ana

Department of Internal Medicine, Faculty of Medicine, Universitas Islam Indonesia
(P-152) The Use of Medication Among People with Stage 2 Hypertension: Findings from an Indonesian Cross-sectional Study
Ana Fauziyati
Favorite
Febrinasari, Ratih Puspita

Faculty of Medicine, Universitas Sebelas Maret
(P-495) Persistence to Treatment After Percutaneous Coronary Intervention for Acute Coronary Syndrome Patients as a Cost-saving Opportunities in Indonesia
Ratih Puspita Febrinasari
Favorite
Fernandes, Maria Raquel

São Paulo State University (UNESP)
(P-459) Efficacy and Effectiveness of Mobile Health Technologies to Improve Breastfeeding: Scoping Review
Maria Raquel Fernandes
Favorite
Ferrara, Lucia

Centre of Research on Health and Social Care Management, SDA Bocconi School of Management (Bocconi University)
(P-480) From Contact Coverage to Effective Coverage of Community Care for Patients with Severe Mental Disorders: A Real-world Investigation from Italy
Lucia Ferrara
Favorite
Ferrara, Pietro

Center for Public Health Research (CESP), University of Milan – Bicocca, Milan, Italy
(P-087) Impact of COVID-19 Outbreak on Antidepressants Utilization: A Real-word Drug-utilization Study Based on Tuscany Healthcare Administrative Databases
Pietro Ferrara
Favorite
Ferraro, Sara

University of Pisa
(P-054) Validation Test for Algorithms to Identify Rheumatoid Arthritis Patients in the Tuscan Healthcare Administrative Databases
Sara Ferraro
Favorite
(P-059) Diagnostic Delay, Effectiveness and Safety Outcomes in a Real-world Cohort of Patients with Crohn’s Disease: Data from Administrative Databases in Tuscany, Italy
Sara Ferraro
Favorite
(P-085) Trajectories of oral budesonide use in Crohn's disease cohort of Tuscan patients (Italy)
Sara Ferraro
Favorite
(P-086) Adherence to Mesalazine and Identification of Patients with Ulcerative Colitis in Healthcare Administrative Databases of Tuscany (Italy)
Sara Ferraro
Favorite
(P-409) Utilization Patterns and Healthcare Accesses of Jaki Used in Rheumatoid Arthritis Patients in Tuscany: The LEONARDO Study
Sara Ferraro
Favorite
Filion, Kristian

Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada
(P-498) Sulfonylureas and the Risk of Ventricular Arrhythmias Among Patients with Type 2 Diabetes: A Systematic Review of Observational Studies
Kristian Filion
Favorite
(P-518) Effectiveness and Safety of Direct Oral Anticoagulants Among Patients with Non-valvular Atrial Fibrillation and Liver Disease: A Population-based Cohort Study
Kristian Filion
Favorite
(P-580) 5-alpha Reductase Inhibitors and the Risk of Anemia Among Men with Benign Prostatic Hyperplasia
Kristian Filion
Favorite
(P-621) Association Between DPP-4 Inhibitors and COVID-19 Related Outcomes Among Patients with Type 2 Diabetes
Kristian Filion
Favorite
(P-625) Utilization and Long-term Persistence of Direct Oral Anticoagulants Among Patients with Non-valvular Atrial Fibrillation and Liver Disease
Kristian Filion
Favorite
Filippi, Matteo

Direzione Medica di Presidio, University Hospital of Pisa
(P-054) Validation Test for Algorithms to Identify Rheumatoid Arthritis Patients in the Tuscan Healthcare Administrative Databases
Matteo Filippi
Favorite
Finckh, Axel

Division of Rheumatology, University Hospitals Geneva, Geneva, Switzerland
(P-115) Comparison of Rheumatic Patients Across Body Mass Index Categories
Axel Finckh
Favorite
Fini, Elisabetta

Medical Specialization School of Pharmacology, University of Pisa
(P-409) Utilization Patterns and Healthcare Accesses of Jaki Used in Rheumatoid Arthritis Patients in Tuscany: The LEONARDO Study
Elisabetta Fini
Favorite
Fisk, John

Nova Scotia Health Authority
(P-208) The Disease-modifying Drugs for Multiple Sclerosis and Subsequent Health Service Use: A Population-based Study
John Fisk
Favorite
Flach, Clare

IQVIA Ltd
(P-338) A Proof of Concept Study to Test the E-CORE Network in Studying Safety and Effectiveness of Treatments in COVID-19 Patients
Clare Flach
Favorite
Fleming, Sean

Department of Pharmaceutical Health Services Research, University of Maryland
(P-189) Low Rates of Bone-active Medication Utilization from 2013-2017 by Provider Type for Beneficiaries Aged 65+ with Medicare Part D
Sean Fleming
Favorite
(P-534) Impacts of Prescription Drug Monitoring Program on Patients with Cancer
Sean Fleming
Favorite
Forbes, Harriet

LSHTM
(P-586) Association Between the Use of Oral Anticoagulant and Risk of Adverse COVID-19 Outcomes: An Opensafely Analysis
Harriet Forbes
Favorite
Fornari, Carla

Center for Public Health Research (CESP), University of Milan – Bicocca, Milan, Italy
(P-087) Impact of COVID-19 Outbreak on Antidepressants Utilization: A Real-word Drug-utilization Study Based on Tuscany Healthcare Administrative Databases
Carla Fornari
Favorite
Fornili, Marco

Unit of Medical Statistics, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
(P-054) Validation Test for Algorithms to Identify Rheumatoid Arthritis Patients in the Tuscan Healthcare Administrative Databases
Marco Fornili
Favorite
Fortin, Élise

Institut national de santé publique du Québec
(P-500) Impact of Chronic Diseases on the Adherence to Guidelines for the Treatment of Urinary Tract Infection in Quebec, Canada
Élise Fortin
Favorite
Fortin, Paul

CHU de Québec - Université Laval
(P-535) Retinal Toxicity in a Multinational Inception Cohort of Systemic Lupus Patients on Hydroxychloroquine
Paul Fortin
Favorite
(P-536) Flares After Hydroxychloroquine Reduction or Discontinuation in a Multinational Inception Cohort of Systemic Lupus
Paul Fortin
Favorite
Francis, Jennie

Eli Lilly & Company
(P-192) Patient Characteristics, Pain Treatment Patterns, and Incidence of Total Joint Replacement in a Population with Osteoarthritis
Jennie Francis
Favorite
Franco, Carolina

UFOP - Universidade Federal de Ouro Preto
(P-553) Pharmacists Role in Patient Safety: Evaluation of Dispensing Errors in a Regional Hospital
Carolina Franco
Favorite
Franklin, Jessica

Optum
(P-531) Role of D-dimer on Serious Outcomes Among Patients Hospitalized with COVID-19
Jessica Franklin
Favorite
Franzén, Stefan

School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; National Diabetes Register, Centre of Registers Västra Götaland, Gothenburg, Sweden
(P-371) Swedish covid-19 Investigation for Future Insights – a Population Epidemiology Approach Using Register Linkage (SCIFI- PEARL)
Stefan Franzén
Favorite
(P-372) Impact of Statin Treatment on COVID-19 Risk and Outcome – a Potential Positive Effect on Survival
Stefan Franzén
Favorite
Franzoni, Carla

RTI Health Solutions, Barcelona, Spain
(P-567) SIGMA Consortium: A New Era of Collaboration to Study the Safety and Effectiveness of Medical Interventions
Carla Franzoni
Favorite
Fredericksen, Rob

University of Washington
(P-037) Vaporized Nicotine (E-cig) Use Among People with HIV in Care in the US
Rob Fredericksen
Favorite
Freeman, Patricia R

University of Kentucky
(P-347) Variation Among Pharmacists in Calculating Days’ Supply
Patricia R Freeman
Favorite
(P-485) Predictors of Concomitant Use of Opioids and Gabapentin in the National Alzheimer's Coordinating Center Database
Patricia R Freeman
Favorite
Friedman, Mark

Panalgo
(P-034) Thrombotic and Cardiovascular Events Among Patients Hospitalized with COVID-19: Findings from a Large EHR Database
Mark Friedman
Favorite
Fried, Michael

University of North Carolina, Chapel Hill, North Carolina
(P-627) Evaluation of Machine-learning Algorithms for Predicting Direct-acting Antiviral Treatment Failure in Patients with Chronic Hepatitis C: An HCV-TARGET Analysis
Michael Fried
Favorite
Fronstin, Michael

Kantar Health
(P-451) Creating High Quality External Control Arms from RWD in Support of Regulatory Decision Making
Michael Fronstin
Favorite
Fr�chtenicht, Charlotta

F. Hoffmann-La Roche AG
(P-056) Genetic Heterogeneity Patterns of Electronic Medical Record (EMR)-Derived Race Groups in a Deidentified Clinico-genomic Database (CGDB)
Charlotta Fr�chtenicht
Favorite
Fryzek, Jon

EpidStrategies, Rockville, MD
(P-203) Systematic Literature Review (SLR) of Respiratory Syncytial Virus (RSV) Burden and Health Care Utilization (HCU) Among Infants in the United States (US)
Jon Fryzek
Favorite
(P-234) Molecular Epidemiology Study of Interferon Gamma (IFN-γ) Expression in Urothelial Bladder Cancer (UBC)
Jon Fryzek
Favorite
Fu, Chaowei

School of Public Health, Fudan University
(P-463) Comparative Analysis on the Evolution of Antimicrobial Resistance Surveillance and Governance Between China and the United States
Chaowei Fu
Favorite
Fujiwara, Masakazu

SHIONOGI & CO., LTD.
(P-017) Comparison of the Incidence of Bleeding Between Anti-influenza Drugs Among Outpatients for the Influenza Virus Infection: A Retrospective Study Using an Employment-based Health Insurance Claims Database in Japan
Masakazu Fujiwara
Favorite
Fulone, Izabela

University of Sorocaba, S�o Paulo, Brazil
(P-074) Sex Difference, Label Indications and Trend in Atypical Antipsychotics Use in Early-onset Schizophrenia: A Nationwide Cross-sectional Study
Izabela Fulone
Favorite
Furiesi, Folco

Azienda Ospedaliera Universitaria Senese, Siena
(P-141) Using Administrative Data and the Regional Pathology Registry of Tuscany to Describe First-line Pharmacotherapy and Survival of Patients with Non-resectable Non-small Cell Lung Cancer from 2009 to 2019
Folco Furiesi
Favorite
Furtek, Christ

Clinical Sciences and Study Management, Merck & Co., Inc.
(P-321) Epidemiology of Treatment Resistant Depression in the US
Christ Furtek
Favorite
Furu, Kari

Norwegian Institute of Public Health
(P-245) Use of Non-insulin Antidiabetic Drugs in Children and Young Adults – a Scandinavian Drug Utilization Study from 2010-2019
Kari Furu
Favorite
Fury, Matthew

Regeneron Pharmaceuticals, Inc., Tarrytown, NY
(P-574) Frequency, Characteristics, and Subsequent Treatment (Tx) of Real-world Patients (pts) Who Discontinue Hedgehog Inhibitors (HHIs) as First-line (1L) Systemic Tx for Advanced Basal Cell Carcinoma (aBCC)
Matthew Fury
Favorite